Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

NRC okays U.S. isotope plant construction application

SHINE Medical Technologies, a Wisconsin-based producer of medical isotope technologies, announced Dec. 3 that the U.S. Nuclear Regulatory Committee (NRC) has accepted the second and final portion of their application for a construction permit to build an accelerator plant for medical isotopes including molybdenum-99, which would in turn create a U.S. supply of technetium-99.

Strut-based breast brachytherapy associate with low risk of recurrence, study shows

Cianna Medical, Inc., a women’s health company, today announced the outcomes of a large, retrospective study demonstrating the safety and efficacy of the SAVI® breast brachytherapy applicator. Researchers reported favorably low recurrence rates, high rates of survival and excellent cosmetic outcomes.

COCIR Code of Conduct Signed In Argentina

BRUSSELS – 16 December 2013 – COCIR company members GE, Philips, Siemens and also Griensu S.A. signed the first COCIR Code of Conduct in Latin America on 10 December 2013 at the CADIEM Chamber of Medical Equipment Manufacturers, Importers and Distributors in Argentina.

Contrast agent may cause brain abnormalities

A link between gadolinium-based contrast agents (Gd-CM) and abnormalities on brain MRI has been confirmed for the first time, according to a study published online Dec. 17 in Radiology. 

Several new genes identified in Alzheimer’s pathology

A Large-scale DNA analysis has led to the discovery of 11 new genes involved in the development of Alzheimer’s disease, according to a study published Oct. 27 in Nature Genetics.

Early detection of MS possible with novel molecular sensor

Using a molecular sensor that finds the protein fibrinogen in the blood-brain barrier, researchers are able to detect early signs of multiple sclerosis (MS) before any outward symptoms of disease. This could lead to better therapies provided earlier in the disease process, according to a study published Nov. 29 in the Annals of Neurology.

Blood-brain barrier cells could unlock new Alzheimer’s disease diagnostics and therapy

Targeting the loss of blood-brain barrier cells now implicated in the development of Alzheimer’s disease (AD) may lead to a new diagnostic paradigm and a way forward for drug therapies that improve neurovascular health, according to a study published Dec. 13 in Nature Communications.

New vitamin B12 cancer biomarker on the block

An investigative SPECT/CT imaging agent targets tumor cells via a vitamin B12 carrier, according to research published online Dec. 12 by the Journal of Nuclear Medicine.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.